Adjuvant combination formulations

摘要

Described is an antigenic composition comprising a selected antigen in combination with a adjuvant comprising: a) an aminoalkyl glucosamine phosphate (AGP) compound, preferably 2-[(R)-3-Tetradecanoyoxytetradecanoylamino]ethyl 2-Deoxy-4-O-phosphono-3-O[(R)-3-Tetradecanoyoxytetradecanoyl]-2-[(R)-3-Tetradecanoyoxytetradecanoylamino]-beta-D-glucopyranoside (AGP compound 529) b) granulocyte macrophage stimulating factor or interleukin-12